Antigen-specific TCR signatures of cytomegalovirus infection

Journal of Immunology

Volumn 202, Issue 3, 2019, Pages 979-990

  Huth, Alina ^a,b   Liang, Xiaoling ^a,d   Krebs, Stefan ^c   Blum, Helmut ^c   Moosmann, Andreas ^a,b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b Deutsches Institut für Neurodegenerative Erkrankungen Site Munich   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d HRYZ Biotech Co   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MESSENGER RNA; T LYMPHOCYTE RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; TRANSCRIPTOME; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN SPECIFICITY; ARTICLE; BETA CHAIN; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLONAL VARIATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; EX VIVO STUDY; HAPLOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; CELL CULTURE; CYTOMEGALOVIRUS; GENETICS; IMMUNOLOGY;

ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITOPES, T-LYMPHOCYTE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TRANSCRIPTOME;

EID: 85060295247     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1801401     Document Type: Article

References (76)

1. Cwynarski, K., J. Ainsworth, M. Cobbold, S. Wagner, P. Mahendra, J. Apperley, J. Goldman, C. Craddock, and P. A. Moss. 2001. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. Blood 97: 1232–1240.
2. Hebart, H., S. Daginik, S. Stevanovic, U. Grigoleit, A. Dobler, M. Baur, G. Rauser, C. Sinzger, G. Jahn, J. Loeffler, et al. 2002. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Blood 99: 3830–3837.
3. Boeckh, M. 2011. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology (Am. Soc. Hematol. Educ. Program) 2011: 305–309.
4. Chemaly, R. F., S. Chou, H. Einsele, P. Griffiths, R. Avery, R. R. Razonable, K. M. Mullane, C. Kotton, J. Lundgren, T. E. Komatsu, et al; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum. 2018. Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials. Clin. Infect. Dis. DOI: 10.1093/cid/ ciy696.
5. Roddie, C., and K. S. Peggs. 2017. Immunotherapy for transplantation-associated viral infections. J. Clin. Invest. 127: 2513–2522.
6. van der Heiden, P., E. Marijt, F. Falkenburg, and I. Jedema. 2018. Control of cytomegalovirus viremia after allogeneic stem cell transplantation: a review on CMV-specific T cell reconstitution. Biol. Blood Marrow Transplant. 24: 1776–1782.
7. Crough, T., and R. Khanna. 2009. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22: 76–98.
8. Halenius, A., C. Gerke, and H. Hengel. 2015. Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets—but how many arrows in the quiver? Cell. Mol. Immunol. 12: 139–153.
9. Noriega, V., V. Redmann, T. Gardner, and D. Tortorella. 2012. Diverse immune evasion strategies by human cytomegalovirus. Immunol. Res. 54: 140–151.
10. Smith, C., S. Gras, R. M. Brennan, N. L. Bird, S. A. Valkenburg, K. A. Twist, J. M. Burrows, J. J. Miles, D. Chambers, S. Bell, et al. 2014. Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire. Sci. Rep. 4: 3993.
11. Kern, F., I. P. Surel, N. Faulhaber, C. Frömmel, J. Schneider-Mergener, C. Schönemann, P. Reinke, and H. D. Volk. 1999. Target structures of the CD8 (+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J. Virol. 73: 8179–8184.
12. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J. Virol. 70: 7569–7579.
13. Manley, T. J., L. Luy, T. Jones, M. Boeckh, H. Mutimer, and S. R. Riddell. 2004. Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infection. Blood 104: 1075–1082.
14. Bunde, T., A. Kirchner, B. Hoffmeister, D. Habedank, R. Hetzer, G. Cherepnev, S. Proesch, P. Reinke, H. D. Volk, H. Lehmkuhl, and F. Kern. 2005. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201: 1031–1036.
15. Sacre, K., S. Nguyen, C. Deback, G. Carcelain, J. P. Vernant, V. Leblond, B. Autran, and N. Dhedin. 2008. Expansion of human cytomegalovirus (HCMV) immediate-early 1-specific CD8+ T cells and control of HCMV replication after allogeneic stem cell transplantation. J. Virol. 82: 10143–10152.
16. Reddehase, M. J., W. Mutter, K. Münch, H. J. Bühring, and U. H. Koszinowski. 1987. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61: 3102–3108.
17. Ameres, S., J. Mautner, F. Schlott, M. Neuenhahn, D. H. Busch, B. Plachter, and A. Moosmann. 2013. Presentation of an immunodominant immediate-early CD8+ T cell epitope resists human cytomegalovirus immunoevasion. PLoS Pathog. 9: e1003383.
18. Ameres, S., K. Besold, B. Plachter, and A. Moosmann. 2014. CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity. J. Immunol. 192: 5894–5905.
19. + T-cell repertoire in older people. Front. Immunol. 8: 1776.
20. Kim, S., S. Lee, J. Shin, Y. Kim, I. Evnouchidou, D. Kim, Y. K. Kim, Y. E. Kim, J. H. Ahn, S. R. Riddell, et al. 2011. Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat. Immunol. 12: 984–991.
21. Padovan, E., G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, and A. Lanzavecchia. 1993. Expression of two T cell receptor alpha chains: dual receptor T cells. Science 262: 422–424.
22. Davis, M. M., and P. J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. [Published erratum appears in 1988 Nature 335: 744]. Nature 334: 395–402.
23. Mackelprang, R., C. S. Carlson, L. Subrahmanyan, R. J. Livingston, M. A. Eberle, and D. A. Nickerson. 2002. Sequence variation in the human T-cell receptor loci. Immunol. Rev. 190: 26–39.
24. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384: 134–141.
25. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky. 1999. A direct estimate of the human alphabeta T cell receptor diversity. Science 286: 958–961.
26. Robins, H. S., P. V. Campregher, S. K. Srivastava, A. Wacher, C. J. Turtle, O. Kahsai, S. R. Riddell, E. H. Warren, and C. S. Carlson. 2009. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114: 4099–4107.
27. Robins, H. S., S. K. Srivastava, P. V. Campregher, C. J. Turtle, J. Andriesen, S. R. Riddell, C. S. Carlson, and E. H. Warren. 2010. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci. Transl. Med. 2: 47ra64.
28. Qi, Q., Y. Liu, Y. Cheng, J. Glanville, D. Zhang, J. Y. Lee, R. A. Olshen, C. M. Weyand, S. D. Boyd, and J. J. Goronzy. 2014. Diversity and clonal selection in the human T-cell repertoire. Proc. Natl. Acad. Sci. USA 111: 13139–13144.
29. Miconnet, I., A. Marrau, A. Farina, P. Taffé, S. Vigano, A. Harari, and G. Pantaleo. 2011. Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure. J. Immunol. 186: 7039–7049.
30. Price, D. A., J. M. Brenchley, L. E. Ruff, M. R. Betts, B. J. Hill, M. Roederer, R. A. Koup, S. A. Migueles, E. Gostick, L. Wooldridge, et al. 2005. Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J. Exp. Med. 202: 1349–1361.
31. Venturi, V., H. Y. Chin, T. E. Asher, K. Ladell, P. Scheinberg, E. Bornstein, D. van Bockel, A. D. Kelleher, D. C. Douek, D. A. Price, and M. P. Davenport. 2008. TCR beta-chain sharing in human CD8+ T cell responses to cytomegalovirus and EBV. J. Immunol. 181: 7853–7862.
32. Freeman, J. D., R. L. Warren, J. R. Webb, B. H. Nelson, and R. A. Holt. 2009. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res. 19: 1817–1824.
33. Dash, P., A. J. Fiore-Gartland, T. Hertz, G. C. Wang, S. Sharma, A. Souquette, J. C. Crawford, E. B. Clemens, T. H. O. Nguyen, K. Kedzierska, et al. 2017. Quantifiable predictive features define epitope-specific T cell receptor repertoires. Nature 547: 89–93.
34. Glanville, J., H. Huang, A. Nau, O. Hatton, L. E. Wagar, F. Rubelt, X. Ji, A. Han, S. M. Krams, C. Pettus, et al. 2017. Identifying specificity groups in the T cell receptor repertoire. Nature 547: 94–98.
35. Klarenbeek, P. L., E. B. Remmerswaal, I. J. ten Berge, M. E. Doorenspleet, B. D. van Schaik, R. E. Esveldt, S. D. Koch, A. ten Brinke, A. H. van Kampen, F. J. Bemelman, et al. 2012. Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years. PLoS Pathog. 8: e1002889.
36. Suessmuth, Y., R. Mukherjee, B. Watkins, D. T. Koura, K. Finstermeier, C. Desmarais, L. Stempora, J. T. Horan, A. Langston, M. Qayed, et al. 2015. CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRb repertoire. Blood 125: 3835–3850.
37. Moosmann, A., N. Khan, M. Cobbold, C. Zentz, H. J. Delecluse, G. Hollweck, A. D. Hislop, N. W. Blake, D. Croom-Carter, B. Wollenberg, et al. 2002. B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood 100: 1755–1764.
38. Bolotin, D. A., S. Poslavsky, I. Mitrophanov, M. Shugay, I. Z. Mamedov, E. V. Putintseva, and D. M. Chudakov. 2015. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12: 380–381.
39. Gary, R., M. Aigner, S. Moi, S. Schaffer, A. Gottmann, S. Maas, R. Zimmermann, J. Zingsem, J. Strobel, A. Mackensen, et al. 2018. Clinical-grade generation of peptide-stimulated CMV/EBV-specific T cells from G-CSF mobilized stem cell grafts. J. Transl. Med. 16: 124.
40. Gerdemann, U., J. M. Keirnan, U. L. Katari, R. Yanagisawa, A. S. Christin, L. E. Huye, S. K. Perna, S. Ennamuri, S. Gottschalk, M. K. Brenner, et al. 2012. Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections. Mol. Ther. 20: 1622–1632.
41. Gragert, L., A. Madbouly, J. Freeman, and M. Maiers. 2013. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum. Immunol. 74: 1313–1320.
42. Weekes, M. P., M. R. Wills, K. Mynard, A. J. Carmichael, and J. G. Sissons. 1999. The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J. Virol. 73: 2099–2108.
43. Yewdell, J. W. 2005. The seven dirty little secrets of major histocompatibility complex class I antigen processing. Immunol. Rev. 207: 8–18.
44. Ameres, S., X. Liang, M. Wiesner, J. Mautner, and A. Moosmann. 2015. A diverse repertoire of CD4 T cells targets the immediate-early 1 protein of human cytomegalovirus. Front. Immunol. 6: 598.
45. Wiesner, M., C. Zentz, M. H. Hammer, M. Cobbold, F. Kern, H. J. Kolb, W. Hammerschmidt, R. Zeidler, and A. Moosmann. 2005. Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines. Eur. J. Immunol. 35: 2110–2121.
46. Brennan, R. M., J. Petersen, M. A. Neller, J. J. Miles, J. M. Burrows, C. Smith, J. McCluskey, R. Khanna, J. Rossjohn, and S. R. Burrows. 2012. The impact of a large and frequent deletion in the human TCR b locus on antiviral immunity. J. Immunol. 188: 2742–2748.
47. Dziubianau, M., J. Hecht, L. Kuchenbecker, A. Sattler, U. Stervbo, C. Rödelsperger, P. Nickel, A. U. Neumann, P. N. Robinson, S. Mundlos, et al. 2013. TCR repertoire analysis by next generation sequencing allows complex differential diagnosis of T cell-related pathology. Am. J. Transplant. 13: 2842–2854.
48. Emerson, R. O., W. S. DeWitt, M. Vignali, J. Gravley, J. K. Hu, E. J. Osborne, C. Desmarais, M. Klinger, C. S. Carlson, J. A. Hansen, et al. 2017. Immuno-sequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire. Nat. Genet. 49: 659–665.
49. Sylwester, A. W., B. L. Mitchell, J. B. Edgar, C. Taormina, C. Pelte, F. Ruchti, P. R. Sleath, K. H. Grabstein, N. A. Hosken, F. Kern, et al. 2005. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202: 673–685.
50. Tan, L. C., N. Gudgeon, N. E. Annels, P. Hansasuta, C. A. O’Callaghan, S. Rowland-Jones, A. J. McMichael, A. B. Rickinson, and M. F. Callan. 1999. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 162: 1827–1835.
51. + TCR repertoires to immunodominant viral antigens. Cell Rep. 19: 569–583.
52. Lehner, P. J., E. C. Wang, P. A. Moss, S. Williams, K. Platt, S. M. Friedman, J. I. Bell, and L. K. Borysiewicz. 1995. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J. Exp. Med. 181: 79–91.
53. Miles, J. J., N. A. Borg, R. M. Brennan, F. E. Tynan, L. Kjer-Nielsen, S. L. Silins, M. J. Bell, J. M. Burrows, J. McCluskey, J. Rossjohn, and S. R. Burrows. 2006. TCR alpha genes direct MHC restriction in the potent human T cell response to a class I-bound viral epitope. J. Immunol. 177: 6804–6814.
54. Klinger, M., F. Pepin, J. Wilkins, T. Asbury, T. Wittkop, J. Zheng, M. Moorhead, and M. Faham. 2015. Multiplex identification of antigen-specific T cell receptors using a combination of immune assays and immune receptor sequencing. PLoS One 10: e0141561.
55. Trautmann, L., M. Rimbert, K. Echasserieau, X. Saulquin, B. Neveu, J. Dechanet, V. Cerundolo, and M. Bonneville. 2005. Selection of T cell clones expressing high-affinity public TCRs within human cytomegalovirus-specific CD8 T cell responses. J. Immunol. 175: 6123–6132.
56. Dong, L., P. Li, T. Oenema, C. L. McClurkan, and D. M. Koelle. 2010. Public TCR use by herpes simplex virus-2-specific human CD8 CTLs. J. Immunol. 184: 3063–3071.
57. Misko, I. S., S. M. Cross, R. Khanna, S. L. Elliott, C. Schmidt, S. J. Pye, and S. L. Silins. 1999. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease. Proc. Natl. Acad. Sci. USA 96: 2279–2284.
58. Gratama, J. W., J. W. van Esser, C. H. Lamers, C. Tournay, B. Löwenberg, R. L. Bolhuis, and J. J. Cornelissen. 2001. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. Blood 98: 1358–1364.
59. Wagner, H. J., Y. C. Cheng, M. H. Huls, A. P. Gee, I. Kuehnle, R. A. Krance, M. K. Brenner, C. M. Rooney, and H. E. Heslop. 2004. Prompt versus preemptive intervention for EBV lymphoproliferative disease. Blood 103: 3979–3981.
60. Iancu, E. M., P. Corthesy, P. Baumgaertner, E. Devevre, V. Voelter, P. Romero, D. E. Speiser, and N. Rufer. 2009. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time. J. Immunol. 183: 319–331.
61. Koning, D., A. I. Costa, I. Hoof, J. J. Miles, N. M. Nanlohy, K. Ladell, K. K. Matthews, V. Venturi, I. M. Schellens, J. A. Borghans, et al. 2013. CD8+ TCR repertoire formation is guided primarily by the peptide component of the antigenic complex. J. Immunol. 190: 931–939.
62. Fazou, C., H. Yang, A. J. McMichael, and M. F. Callan. 2001. Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis. Arthritis Rheum. 44: 2038–2045.
63. Lim, A., L. Trautmann, M. A. Peyrat, C. Couedel, F. Davodeau, F. Romagné, P. Kourilsky, and M. Bonneville. 2000. Frequent contribution of T cell clonotypes with public TCR features to the chronic response against a dominant EBV-derived epitope: application to direct detection of their molecular imprint on the human peripheral T cell repertoire. J. Immunol. 165: 2001–2011.
64. Miles, J. J., D. Elhassen, N. A. Borg, S. L. Silins, F. E. Tynan, J. M. Burrows, A. W. Purcell, L. Kjer-Nielsen, J. Rossjohn, S. R. Burrows, and J. McCluskey. 2005. CTL recognition of a bulged viral peptide involves biased TCR selection. J. Immunol. 175: 3826–3834.
65. Stadinski, B. D., K. Shekhar, I. Gómez-Touriño, J. Jung, K. Sasaki, A. K. Sewell, M. Peakman, A. K. Chakraborty, and E. S. Huseby. 2016. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat. Immunol. 17: 946–955.
66. Kozich, J. J., S. L. Westcott, N. T. Baxter, S. K. Highlander, and P. D. Schloss. 2013. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl. Environ. Microbiol. 79: 5112–5120.
67. Klinger, M., K. Kong, M. Moorhead, L. Weng, J. Zheng, and M. Faham. 2013. Combining next-generation sequencing and immune assays: a novel method for identification of antigen-specific T cells. PLoS One 8: e74231.
68. Paillard, F., G. Sterkers, and C. Vaquero. 1990. Transcriptional and post-transcriptional regulation of TcR, CD4 and CD8 gene expression during activation of normal human T lymphocytes. EMBO J. 9: 1867–1872.
69. Braendstrup, P., S. Justesen, T. Osterbye, L. L. Nielsen, R. Mallone, L. Vindeløv, A. Stryhn, and S. Buus. 2013. MHC class II tetramers made from isolated recombinant a and b chains refolded with affinity-tagged peptides. [Published erratum appears in 2013 PLoS One. 8.] PLoS One 8: e73648.
70. Schlott, F., D. Steubl, S. Ameres, A. Moosmann, S. Dreher, U. Heemann, V. Hösel, D. H. Busch, and M. Neuenhahn. 2018. Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells. PLoS One 13: e0193554.
71. Rius, C., M. Attaf, K. Tungatt, V. Bianchi, M. Legut, A. Bovay, M. Donia, P. Thor Straten, M. Peakman, I. M. Svane, et al. 2018. Peptide-MHC class I tetramers can fail to detect relevant functional T cell clonotypes and underestimate antigen-reactive T cell populations. J. Immunol. 200: 2263–2279.
72. Shugay, M., D. V. Bagaev, I. V. Zvyagin, R. M. Vroomans, J. C. Crawford, G. Dolton, E. A. Komech, A. L. Sycheva, A. E. Koneva, E. S. Egorov, et al. 2018. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res. 46(D1): D419–D427.
73. + TCRab repertoire in immunosuppressed lung transplant recipients. Immunol. Cell Biol. 95: 77–86.
74. van Heijst, J. W., I. Ceberio, L. B. Lipuma, D. W. Samilo, G. D. Wasilewski, A. M. Gonzales, J. L. Nieves, M. R. van den Brink, M. A. Perales, and E. G. Pamer. 2013. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat. Med. 19: 372–377.
75. Amir, A. L., L. J. D’Orsogna, D. L. Roelen, M. M. van Loenen, R. S. Hagedoorn, R. de Boer, M. A. van der Hoorn, M. G. Kester, I. I. Doxiadis, J. H. Falkenburg, et al. 2010. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115: 3146–3157.
76. Schub, A., I. G. Schuster, W. Hammerschmidt, and A. Moosmann. 2009. CMV-specific TCR-transgenic T cells for immunotherapy. J. Immunol. 183: 6819–6830.